Cerevel Therapeutics Holdings, Inc. CERE
44.96 +44.96
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -447.26M | -367.85M | -220.10M | -149.12M | -83.46M | |
| -432.84M | -351.51M | -225.33M | -152.14M | -128.39M | |
| -2.67 | -2.32 | -1.65 | -2.01 | -2.90 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 418.43M | 138.39M | 197.22M | 387.82M | 83.68M | |
| 1.24B | 1.02B | 688.92M | 445.27M | 120.81M | |
| 569.55M | 496.58M | 110.19M | 60.75M | 42.98M | |
| 480.78M | 426.92M | 70.09M | 33.01M | 28.41M | |
| 673.75M | 521.24M | 578.73M | 384.52M | 77.82M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -342.30M | -293.19M | -178.55M | -117.80M | -70.72M | |
| 73.72M | -388.83M | -435.66M | -18.89M | -1.10M | |
| 548.62M | 623.19M | 423.60M | 440.83M | 60.06M | |
| -3.81M | -3.95M | -10.50M | -18.89M | -1.10M | |
| 280.04M | -58.83M | -190.60M | 304.14M | -11.76M |